A curious phenomenon seen by oncologists, that morning patients do better than those receiving afternoon infusions, gains ...

By analyzing tissue from patients with Parkinson's disease, and animal and cellular models of the disease, a research team ...

The most robust evidence to date shows that people with a type of lung cancer lived longer if they received immunotherapy before 3pm ...

Study reveals how pancreatic cancer cells may hide from the immune system—and how scientists hope to unmask them with ...

Cardiologists have spent decades trying to stabilize the fatty plaques that clog arteries, but a new wave of immunotherapy is ...

New results from a clinical trial co-led by UCLA investigators demonstrate how treating desmoplastic melanoma, a rare and ...

Pembrolizumab works by blocking a mechanism that cancer cells use to evade detection by the immune system, according to Drugs.com. The U.S. Food and Drug Administration (FDA) first approved it in 2014 ...

Long-term clinical trials show patients with stage four kidney cancer are living a decade or more beyond previous ...

Cancer immunotherapy has been a game-changer, but many tumors still find ways to slip past the immune system. New research ...

Scientists have designed an immunotherapy that reduces plaque in the arteries of mice, presenting a possible new treatment strategy against heart disease. The antibody-based therapy could complement ...

The RHOBH alum shared a health update after her father, John Cougar Mellencamp, told the media she was “suffering.” ...